8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Apr 20, 2011)

Filed April 20, 2011For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on April 20, 2011, to report its financial results for the quarter ended March 31, 2011. The filing primarily serves to incorporate by reference the press release announcing these results. Investors should refer to the attached press release (Exhibit 99.1) for detailed financial performance, operational updates, and forward-looking statements for the first quarter of 2011. This 8-K is a standard disclosure mechanism for announcing earnings. The key information for investors will be contained within the press release itself, which outlines the company's performance and financial condition as of and for the period ending March 31, 2011. The Chief Financial Officer, Robert A. Hagemann, signed off on the filing, indicating the official nature of the reported financial information.

Key Highlights

  • 1Quest Diagnostics filed an 8-K on April 20, 2011, to report Q1 2011 financial results.
  • 2The primary purpose of the 8-K is to incorporate by reference a press release detailing the company's financial performance for the quarter ended March 31, 2011.
  • 3Exhibit 99.1 contains the press release with the actual financial results and operational updates.
  • 4Investors need to review the attached press release for specific financial figures and commentary.
  • 5The filing confirms the company's adherence to reporting requirements.
  • 6Robert A. Hagemann, Senior Vice President and Chief Financial Officer, signed the report.

Frequently Asked Questions

The main purpose of this Form 8-K filing is to announce Quest Diagnostics' financial results for the quarter ended March 31, 2011, by incorporating a press release (Exhibit 99.1) that contains this information.

The detailed financial results, operational updates, and commentary for the quarter ended March 31, 2011, are located in the press release attached as Exhibit 99.1 to this 8-K filing.

The report was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated.

This 8-K filing itself does not contain the specific financial numbers. It serves as notification and incorporates by reference a press release (Exhibit 99.1) which contains the detailed financial results for the quarter.